Maynard Um
-
-
-
-
-
-
-
Supernus Pharmaceuticals (SUPN) PT Raised to $55 at Stifel: Portfolio 'Well-Rounded'
-
-
-
-
-
-
-
Piper Sandler Upgrades Supernus Pharmaceuticals (SUPN) to Overweight
-
-
-
-
-
-
-
Supernus gets regulatory clearance for Sage acquisition
-
-
-
-
-
-
-
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN) to Neutral
-
-
-
-
-
-
-
Supernus Pharma (SUPN) Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

